levodopa has been researched along with Liver Cirrhosis in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (73.91) | 18.7374 |
1990's | 2 (8.70) | 18.2507 |
2000's | 2 (8.70) | 29.6817 |
2010's | 2 (8.70) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akamatsu, Y; Fujimori, K; Kawagishi, N; Miyagi, S; Sato, A; Satomi, S; Sekiguchi, S | 1 |
Marín, E; Uribe, M | 1 |
Jeong, SH; Kim, JM; Kim, JS; Kim, SE; Kim, SH; Kim, Y; Kim, YK | 1 |
Butterworth, RF | 1 |
Minagar, A; Shulman, LM; Weiner, WJ | 1 |
Alagna, S; Chiandussi, L; Langer, M; Madeddu, G; Masala, A; Rassu, S; Solinas, A | 1 |
Bali, JP; Bellet-Hermann, H; Cauvet, G; Granier, P; Michel, H; Pons, F; Solere, M | 1 |
Rózga, J; Szczerbań, J | 1 |
Barbieri, C; Borzio, F; Borzio, M; Caldara, R; Ferrari, C; Romussi, M | 1 |
Cohen, KL | 1 |
Cocchi, D; Locatelli, V; Müller, EE; Panerai, AE; Salerno, F | 1 |
Bossone, CM | 1 |
Baldy-Moulinier, M; Bories, P; Michel, H; Passouant, P | 1 |
Favilli, R; Gragnoli, G; Migliarese, G; Palazzuoli, V; Tanganelli, I | 1 |
Altomonte, L; Fedeli, G; Ghirlanda, G; Greco, AV; Manna, R; Rebuzzi, A | 1 |
Ferrari, A; Manenti, F | 1 |
Bianco, A; Borzone, A; Butti, A; Cagossi, M; Civello, IM; Lojacono, L; Nanni, G | 1 |
Falcao, HA; Fischer, JE; Funovics, FJ; Wesdorp, RI | 1 |
Morgan, MY | 1 |
Corenblum, B; Shaffer, EA | 1 |
Alagna, S; Anania, V; Chiandussi, L; Deplano, A; Langer, M; Masala, A; Rovasio, PP | 1 |
Bergonzi, P; Bianco, A; Cagossi, M; Mennuni, G | 1 |
Bianco, A; Borzone, A; Butti, A; Cagossi, M; Fianchini, A; Ghirlanda, G; Lojacono, L; Nanni, G; Suraci, V | 1 |
4 review(s) available for levodopa and Liver Cirrhosis
Article | Year |
---|---|
Treatment of portal systemic encephalopathy: standard and new treatments.
Topics: Bromocriptine; Clinical Trials as Topic; Colon; Dietary Proteins; Disaccharides; Double-Blind Method; Enema; GABA Antagonists; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Laxatives; Levodopa; Liver Cirrhosis; Malnutrition; Metabolic Networks and Pathways; Plant Proteins, Dietary; Sodium Benzoate; Zinc | 1990 |
Parkinsonism in cirrhosis: pathogenesis and current therapeutic options.
Topics: Antiparkinson Agents; Brain Chemistry; Chelating Agents; Dopamine; Dopamine Agents; Humans; Hyperammonemia; Levodopa; Liver Cirrhosis; Liver Transplantation; Manganese Poisoning; Parkinson Disease | 2013 |
Metabolic, endocrine, and drug-induced interference with pituitary function tests: a review.
Topics: Anorexia; Antipsychotic Agents; Depression; Diabetes Mellitus; Drug-Related Side Effects and Adverse Reactions; Endocrine System Diseases; Ethanol; Hormones; Humans; Hypokalemia; Levodopa; Liver Cirrhosis; Metabolic Diseases; Morphine; Obesity; Phenothiazines; Pituitary Function Tests; Pituitary Gland; Starvation; Uremia | 1977 |
The treatment of chronic hepatic encephalopathy.
Topics: Amantadine; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver Cirrhosis; Receptors, GABA-A | 1991 |
1 trial(s) available for levodopa and Liver Cirrhosis
Article | Year |
---|---|
Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Clinical Trials as Topic; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Levodopa; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged | 1980 |
18 other study(ies) available for levodopa and Liver Cirrhosis
Article | Year |
---|---|
Parkinsonism during cyclosporine treatment in liver transplantation: an unusual case report.
Topics: Adult; Cyclosporine; Hepatitis C; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Treatment Outcome | 2008 |
Dopaminergic neuronal integrity in parkinsonism associated with liver cirrhosis.
Topics: Aged; Basal Ganglia; Dopamine Plasma Membrane Transport Proteins; Drug Resistance; Female; Humans; Levodopa; Liver Cirrhosis; Male; Middle Aged; Neurons; Parkinsonian Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes | 2010 |
Reversal of parkinsonism following liver transplantation.
Topics: Acute Disease; Aged; Antiparkinson Agents; Carbidopa; Disease Progression; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Remission Induction; Treatment Outcome; Tremor | 2003 |
Growth hormone (GH) secretion in hepatic encephalopathy.
Topics: Adult; Aged; Female; Growth Hormone; Hepatic Encephalopathy; Humans; Levodopa; Liver; Liver Cirrhosis; Male; Middle Aged; Thyrotropin-Releasing Hormone | 1981 |
[Hepatic encephalopathy].
Topics: Amino Acids; Ammonia; Brain; Hepatic Encephalopathy; Humans; Levodopa; Liver Cirrhosis | 1980 |
Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction.
Topics: Adult; Brain; Carbidopa; Female; Growth Hormone; Humans; Levodopa; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prolactin; Receptors, Dopamine | 1981 |
Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
Topics: Acromegaly; Aged; Animals; Bromocriptine; Dopamine; Drug Interactions; Female; Growth Hormone; Humans; Levodopa; Liver Cirrhosis; Male; Median Eminence; Middle Aged; Prolactin; Rats; Thyrotropin-Releasing Hormone; Time Factors | 1979 |
The liver: a pharmacologic perspective.
Topics: Acetaldehyde; Alcoholism; Chemical and Drug Induced Liver Injury; Diuretics; Drug-Related Side Effects and Adverse Reactions; Ethanol; Hepatic Encephalopathy; Humans; Inactivation, Metabolic; Lactulose; Levodopa; Liver; Liver Cirrhosis; Liver Diseases; Microsomes, Liver; Neomycin; Oxidation-Reduction; Pharmaceutical Preparations; Spironolactone; Vasopressins | 1977 |
[Hepatic encephalopathies; hemodynamic and metabolic study of the influence of ammonia and levodopa].
Topics: Ammonia; Blood Glucose; Carbon Dioxide; Cerebrovascular Circulation; Energy Metabolism; Hepatic Encephalopathy; Humans; Lactates; Levodopa; Liver Cirrhosis; Oxygen; Oxygen Consumption; Pyruvates | 1977 |
[Behavior of plasma IRI, HGH and cortisol after administration of levodopa in patients with hepatic cirrhosis].
Topics: Adult; Amino Acids; Antigens; Blood Glucose; Growth Hormone; Humans; Hydrocortisone; Insulin; Levodopa; Liver; Liver Cirrhosis; Male; Middle Aged | 1976 |
[GH secretion after L-dopa administration in hepatic cirrhosis].
Topics: Adult; Blood Glucose; Growth Hormone; Humans; Insulin; Levodopa; Liver Cirrhosis; Male; Middle Aged; Pituitary Gland; Pituitary Gland, Anterior | 1976 |
[Therapy of coma in liver cirrhosis].
Topics: Adenosine Triphosphate; Ammonia; Arginine; Brain; Colon; Disaccharides; Hepatic Encephalopathy; Humans; Hydroxamic Acids; Intestinal Absorption; Lactulose; Levodopa; Liver Cirrhosis | 1975 |
[Hemodynamic response to the acute treatment with levodopa in cirrhotic patients].
Topics: Hemodynamics; Humans; Levodopa; Liver Cirrhosis; Time Factors | 1975 |
L-dopa in hepatic coma.
Topics: Alcoholism; Blood Pressure; Cardiac Output; Female; Hepatic Encephalopathy; Hepatitis; Humans; Levodopa; Liver Cirrhosis; Male; Middle Aged; Time Factors; Vascular Resistance | 1976 |
Hyperprolactinemia in hepatic encephalopathy may result from impaired central dopaminergic neurotransmission.
Topics: Adult; Carbidopa; Dopamine; Female; Hepatic Encephalopathy; Humans; Hyperprolactinemia; Levodopa; Liver Cirrhosis; Male; Middle Aged; Synaptic Transmission | 1989 |
Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy.
Topics: Adult; Estrogens; Hepatic Encephalopathy; Humans; Isoquinolines; Levodopa; Liver Cirrhosis; Male; Middle Aged; Nomifensine; Prolactin; Thyrotropin-Releasing Hormone | 1985 |
[Hemodynamic, psychometric and EEG evaluation of L-DOPA treatment in patients affected by hepatocirrhosis (author's transl)].
Topics: Brain; Electroencephalography; Hemodynamics; Humans; Levodopa; Liver Cirrhosis; Mental Processes; Psychological Tests | 1974 |
[Hemodynamic response to prolonged treatment with L-dopa in cirrhotic patients].
Topics: Hemodynamics; Humans; Levodopa; Liver Cirrhosis; Parkinson Disease; Time Factors | 1973 |